Irhythm Technologies, INC Form 4 insider transactions

iRhythm Technologies' President and CEO, Quentin S. Blackford, sold 14,059 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

iRhythm Technologies' CFO, Daniel G. Wilson, sold 8,000 shares of common stock for $207.44 per share pursuant to a pre-arranged trading plan.

iRhythm Technologies' Chief Financial Officer, Daniel G. Wilson, sold 5,000 shares of common stock for $175 per share, executed under a pre-arranged 10b5-1 trading plan.

iRhythm Technologies' CFO, Daniel G. Wilson, sold 737 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Technologies' EVP, Chief Risk Officer, Sumi Shrishrimal, sold 653 shares of common stock for $167.12 per share under a pre-arranged 10b5-1 trading plan.

iRhythm Technologies' Chief Accounting Officer, Marc Rosenbaum, sold 226 shares of common stock for $158.93 per share under a pre-arranged trading plan.

Abhijit Talwalkar, a director at iRhythm Technologies, sold shares of IRTC common stock on August 11, 2025, under a pre-arranged 10b5-1 trading plan.

iRhythm Technologies' Chief Commercial Officer, Chad Patterson, sold 2,555 shares of common stock for $158.97 per share, executed under a pre-established Rule 10b5-1 trading plan.

iRhythm Technologies' President and CEO, Quentin S. Blackford, sold 29,000 shares of common stock for approximately $4.67 million through a pre-established Rule 10b5-1 trading plan.

An iRhythm Technologies executive sold 616 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Technologies' Chief Commercial Officer, Chad Patterson, sold 2,707 shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Technologies, Inc. Director Karen K. McGinnis was granted 2,035 restricted stock units, which will vest over three years starting July 7, 2026.

iRhythm Technologies, Inc. Director Kevin C. O'Boyle acquired 2,035 restricted stock units (RSUs) on July 7, 2025, as part of his compensation.

iRhythm Technologies' EVP of Strategy & Corporate Development, Sean Clinton Freeman, was granted 6,761 restricted stock units, vesting over four years starting July 2026.

Minang Turakhia, EVP, CMO & CSO of iRhythm Technologies, Inc., sold 1,420 shares of common stock at $145.41 per share to cover tax withholding obligations related to Restricted Stock Unit vesting.

iRhythm Technologies, Inc.'s Chief Financial Officer, Daniel G. Wilson, sold 3,000 shares of common stock for $150 per share as part of a pre-established Rule 10b5-1 trading plan.

Chad Patterson, Chief Commercial Officer of iRhythm Technologies, Inc., sold 936 shares of common stock for $150 per share on June 23, 2025, pursuant to a Rule 10b5-1 trading plan.

iRhythm Technologies' Chief Commercial Officer, Chad Patterson, sold 363 shares of common stock for $150 per share on June 10, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Sumi Shrishrimal, EVP and Chief Risk Officer of iRhythm Technologies, Inc. (IRTC), reported an acquisition of shares via an Employee Stock Purchase Plan and a subsequent sale to cover tax obligations related to Restricted Stock Unit vesting.

iRhythm Technologies' Chief Accounting Officer, Marc W. Rosenbaum, reported the acquisition of shares through an employee stock purchase plan and the subsequent sale of shares to cover tax obligations related to restricted stock unit vesting.

iRhythm Technologies' Chief Commercial Officer, Chad Patterson, acquired 298 shares of common stock at $71.46 per share through the company's Employee Stock Purchase Plan.

iRhythm Technologies, Inc. President and CEO, Quentin S. Blackford, acquired 297 shares of common stock at $71.46 per share through the company's Employee Stock Purchase Plan.

Minang Turakhia, EVP, CMO & CSO of iRhythm Technologies, Inc., has acquired 318 shares of common stock at $74.72 per share through the company's Employee Stock Purchase Plan.

iRhythm Technologies, Inc. Director Brian B. Yoor reported the acquisition of 1,358 restricted stock units (RSUs) on May 28, 2025, increasing his direct beneficial ownership to 5,598 shares.

iRhythm Technologies, Inc. Director Bruce G. Bodaken was granted 1,358 restricted stock units (RSUs) as part of his compensation, aligning his interests with shareholders.

iRhythm Technologies, Inc. Director Ralph Snyderman was granted 1,358 restricted stock units (RSUs) on May 28, 2025, increasing his beneficial ownership to 13,288 shares.

iRhythm Technologies, Inc. Director Cathleen Noel Bairey Merz was granted 1,358 restricted stock units (RSUs) on May 28, 2025, increasing her direct beneficial ownership to 8,973 shares.

iRhythm Technologies, Inc. Director Abhijit Y Talwalkar was granted 1,358 restricted stock units (RSUs) on May 28, 2025, as part of his compensation, increasing his total beneficial ownership to 20,299 shares.

iRhythm Technologies, Inc. Director Karen Ling was granted 1,358 restricted stock units (RSUs) on May 28, 2025, aligning her interests with shareholders.

iRhythm Technologies, Inc. Director Mark J. Rubash has acquired 1,358 shares of common stock through a Restricted Stock Unit (RSU) grant, increasing his total beneficial ownership to 13,788 shares.